Search Data.gov
Found 11 dataset(s) matching "beta blocker".
-
The evidence base for drug treatment of hypertension is strong. Early trials using thiazide diuretics suggested a shortfall in prevention of coronary heart disease. The superiority of newer...
-
These data represent water and bed sediment samples analyzed for a variety of organic compounds. The samples were collected in streams and rivers in the Chesapeake Bay watershed from 2006-2014. ...
-
Background Iron deficiency (ID) results in ventricular hypertrophy, believed to involve sympathetic stimulation. We hypothesized that with ID 1) intravenous norepinephrine would alter...
-
The publication of the results of the Swedish Trial in Old Patients with Hypertension-2 (STOP-2) and the termination of the doxazocin arm of the Antihypertensive and Lipid Lowering Treatment to...
-
Background Uncertainty remains about the potential harmful effects of antihypertensive therapy on the developing fetus, especially for beta-blockers (βb). ...
-
Over 300 samples were collected in New York, Vermont, and Massachusetts from wastewater treatment facilities (20 locations), drinking water facilities (9 locations), streams (53 locations), lakes...
-
The dataset contains ambient air pollution data and circulating miRNA data of subjects from the CADEE study. This dataset is associated with the following publication: Chen, H., Y. Xu, A....
-
Previous trials (Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure [MERIT-HF], Cardiac Insufficiency Bisoprolol Study [CIBIS] II) have demonstrated a mortality benefit of...
-
Discharges from pharmaceutical manufacturing facilities (PMFs) previously have been identified as important sources of pharmaceuticals to the environment. Yet few studies are available to...
-
Over 300 samples were collected in New York, Vermont, and Massachusetts from wastewater treatment facilities (20 locations), drinking water facilities (9 locations), streams (53 locations), lakes...
-
Recent clinical trials indicate that approximately two-thirds of patients in New York Heart Association (NYHA) class II and III, who comprise almost 90% of patients with heart failure, die...
